FIELD: medicine.
SUBSTANCE: invention relates to use of a peptide having formula Thr-Lys-Pro-Arg-Pro-Gly-Pro (selank) for hepatoprotective effects in acute immobilisation stress.
EFFECT: invention provides a significant increase in hepatic activity of antioxidant enzymes (catalase, SOD), and concentrations of lipid peroxidation products using selank in doses of 100 mcg/kg and 300 mcg/kg.
1 cl, 1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF THR-LYS-PRO-ARG-PRO-GLY-PRO PEPTIDE (SELANK) FOR HEPATOPROTECTIVE IMPACT IN CHRONIC EMOTIONAL-PAIN STRESS | 2016 |
|
RU2629832C1 |
APPLICATION OF PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANG) FOR DYSBIOSIS CORRECTION UNDER CHRONIC IMMOBILIZATION STRESS | 2018 |
|
RU2681217C1 |
APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
USE OF THE PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANK) TO INCREASE BODY RESISTANCE TO ACUTE HYPOTHERMIA | 2019 |
|
RU2709503C1 |
APPLICATION OF THE HIS-PHE-ARG-TRP-PRO-GLY-PRO PEPTIDE FOR THE PREVENTION OF DYSBIOSIS IN CHRONIC IMMOBILIZATION STRESS | 2021 |
|
RU2770583C1 |
USING DELTA SLEEP INDUCING PEPTIDE FOR HEPATOPROTECTIVE EFFECT IN CHRONIC IMMOBILISATION STRESS | 2013 |
|
RU2538686C1 |
METHOD FOR PREVENTING AND TREATING ULCERS OF GASTRO-INTESTINAL TRACT | 2003 |
|
RU2252779C1 |
USE OF PEPTIDE ACTH (4-7) -PGP OF HEPATOPROTECTIVE ACTION | 2013 |
|
RU2528741C1 |
AGENT POSSESSING ANTI-COAGULATING, ANTI-THROMBOCYTIC, ANTI-THROMBOSIS, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC ACTIVITY | 2005 |
|
RU2290195C1 |
ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
Authors
Dates
2016-04-27—Published
2015-04-27—Filed